Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Anthony Lando
AddedMar 31, 2024
UpdatedMay 31, 2026
Anthony Lando

Anthony Lando

CEO, Innovation Factory

Crunchbase

Anthony Lando's Career

Innovation Factory
Innovation Factory

Chicago, IL, US

CEO· C-Suite · Management
Halscion
Halscion

Duluth, GA, US

Board Member· Board
Sebacia
Sebacia

Duluth, GA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Anthony Lando's Career

Innovation Factory
Innovation Factory
Seed$250k322012Chicago, IL, US
CEO· C-Suite · Management

Leadership at Innovation Factory

Tom WeldonTom WeldonCo-Founder
Jonathan KinlayJonathan KinlayCo-Founder
Halscion
Halscion
Series B$13.8M92005Duluth, GA, US
Board Member· Board

Leadership at Halscion

Ronald YamamotoRonald YamamotoBoard Member
Charles WardenCharles WardenBoard Member
Charles LarsenCharles LarsenCo-Founder
Kathleen M. BeauchampKathleen M. BeauchampBoard Member

Similar to Halscion

Halcyon BiomedicalHalcyon BiomedicalFriendswood, TX, USMedical Devicesest. 2010Halcyon BiomedicalFriendswood, TX, US · est. 2010

US-based Halcyon Biomedical innovates medical devices for purifying stored blood, established in 2013.

Pre-Seed · $1.1M1
HealionicsHealionicsSeattle, WA, USMedical Devicesest. 2007HealionicsSeattle, WA, US · est. 2007

Seattle-based Healionics offers innovative vascular grafts for enhanced dialysis patient care.

Series A · $19.4M11
Halo Medical TechnologiesHalo Medical TechnologiesWilmington, DE, USMedical Devicesest. 2012Halo Medical TechnologiesWilmington, DE, US · est. 2012

HALO Medical Technologies: Providing advanced diagnostic ultrasound products and accessories since 2012.

Seed · $210k6
Hs PharmaceuticalsHs PharmaceuticalsGreenville, SC, USDermatological Products, Wound Careest. 2007Hs PharmaceuticalsGreenville, SC, US · est. 2007

HS Pharmaceuticals: Crafting dermatological solutions for wounds and infections since 2007.

Series A · $8.6M8
Sebacia
Sebacia
Series A$101.6M302010Duluth, GA, US
Board Member· Board

Leadership at Sebacia

Beckie RobertsonBeckie RobertsonBoard Member
Neal WalkerNeal WalkerBoard Member
Todd C. BradyTodd C. BradyBoard Member
Dr Jesse I Treu PhDDr Jesse I Treu PhDBoard Member

Anthony Lando's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Anthony Lando

Anwar AlmojarkeshAnwar AlmojarkeshCo-Founder · AmpyDean ModroukasDean ModroukasCEO · InnoveeringDror BermanDror BermanBoard Member · Team8Dennis WigginsDennis WigginsCo-Founder · InnovBotSang LeeSang LeeCEO · FacetoryAgnieszka SkalaAgnieszka SkalaCEO · Innovation Nest